SMAC Mimetics as Therapeutic Agents in HIV Infection
Although combination antiretroviral therapy is extremely effective in lowering HIV RNA to undetectable levels in the blood, HIV persists in latently infected CD4+ T-cells and persistently infected macrophages. In latently/persistently infected cells, HIV proteins have shown to affect the expression...
Guardado en:
Autores principales: | Bengisu Molyer, Ashok Kumar, Jonathan B. Angel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2400c6265cdd4d9db817d85c7f557bea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
BH3-mimetics: recent developments in cancer therapy
por: Paul A. Townsend, et al.
Publicado: (2021) -
HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection
por: Guochun Jiang, et al.
Publicado: (2017) -
Interactions of Monocytes, HIV, and ART Identified by an Innovative scRNAseq Pipeline: Pathways to Reservoirs and HIV-Associated Comorbidities
por: Rosiris León-Rivera, et al.
Publicado: (2020) -
Entry of Polarized Effector Cells into Quiescence Forces HIV Latency
por: Curtis Dobrowolski, et al.
Publicado: (2019) -
HIV Silencing and Inducibility Are Heterogeneous and Are Affected by Factors Intrinsic to the Virus
por: Nicholas J. Norton, et al.
Publicado: (2019)